Eradication or decolonization of methicillin-resistant Staphylococcus aureus carriage: What are we doing and why are we doing it?

Clinical Infectious Diseases

Volumn 44, Issue 2, 2007, Pages 186-189

  Bradley, Suzanne F ^a,b  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b GRECC 11 G   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHLORHEXIDINE; PSEUDOMONIC ACID;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC THERAPY; BACTERIAL COLONIZATION; BACTERIAL GENE; BACTERIAL INFECTION; BACTERIUM CARRIER; DRUG EFFICACY; DRUG USE; DRUG WITHDRAWAL; ERADICATION THERAPY; GASTROINTESTINAL SYMPTOM; HUMAN; INFECTION CONTROL; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MUPA GENE; NONHUMAN; NOTE; PRIORITY JOURNAL; TREATMENT INDICATION;

ANTI-BACTERIAL AGENTS; CARRIER STATE; HUMANS; INFECTION CONTROL; METHICILLIN RESISTANCE; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS;

EID: 33846167422     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/510395     Document Type: Note

References (30)

1. Rennie RP, Jones RN, Mutnick AH, SENTRY Program Study Group. Occurrence and antimicrobial susceptibility patterns of pathogens isolated from skin and soft tissue infections: report from the SENTRY Antimicrobial Surveillance Program (United States and Canada, 2000). Diagn Microbiol Infect Dis 2003; 45:287-93.
2. Diekema DJ, Pfaller MA, Jones RN, SENTRY Participants Group. Age-related trends in pathogen frequency and antimicrobial susceptibility of bloodstream isolates in North American Sentry Antimicrobial Surveillance Program, 1997-2000. Int J Antimicrob Agents 2002; 20:412-8.
3. Jones RN. Resistance patterns among nosocomial pathogens: trends over the past few years. Chest 2001; 119:397S-404S.
4. Muto CA, Jernigan JA, Ostrowsky BE, et al. SHEA guidelines for preventing nosocomial transmission of multidrug resistant strains of Staphylococcus aureus and Enterococcus. Infect Control Hosp Epidemiol 2003; 24:362-86.
5. Simor AE, Phillips E, McGeer A, et al. Randomized controlled trial of chlorhexidine gluconate for washing, intranasal mupirocin, and rifampin and doxycycline versus no treatment for the eradication of methicillin-resistant Staphylococcus aureus colonization. Clin Infect Dis 2007; 44:178-85 (in this issue).
6. Laupland KB, Conly JM. Treatment of Staphylococcus aureus colonization and prophylaxis for infection with topical intranasal mupirocin: an evidence-based review. Clin Infect Dis 2003;37:933-8.
7. Bradley SF. Mupirocin. In: Yu VL, Weber R, Raoult D, eds. Antimicrobial chemotherapy and vaccines. Vol. II: antimicrobial agents. Pittsburgh, PA: Esun Technologies, 2005: 293-303.
8. Bradley SF. Effectiveness of mupirocin in the control of methicillin-resistant Staphylacoccus aureus. Infect Med 1993; 10:23-31.
9. Kluytmans J, van Belkam A, Verbrugh H. Nasal carriage of Staphylococcus aureus: epidemiology, underlying mechanisms, and associated risks. Clin Microbiol Rev 1997; 10: 505-20.
10. Vandenbergh MFQ, Yzerman ED, Belkum AV, et al. Follow-up of Staphylococcus aureus nasal carriage after 8 years: redefining the persistent carrier state. J Clin Microbiol 1999; 37: 3133-40.
11. Nouwen JL, Ott A, Kluytmans-Vandenbergh MFQ, et al. Predicting the Staphylococcus aureus nasal carriage state: derivation and validation of a "culture rule." Clin Infect Dis 2004;39:806-11.
12. Reagen DR, Doebbling BN, Pfaller MA, et al. Elimination of coincident Staphylococcus aureus nasal and hand carriage with intranasal application of mupirocin calcium ointment. Ann Intern Med 1991; 114:101-6.
13. Mody L, Bradley SF, Kauffman CA. Patterns of nasal and extra-nasal colonization with Staphylococcus aureus in long-term care facility residents: role of indwelling devices [abstract 235]. In: Proceedings of the 16th Annual Scientific Meeting, Society for Healthcare Epidemiology of America (Chicago). Chicago, IL: Society for Healthcare Epidemiology of America, 2006.
14. Eveillard M, de Lassence A, Lancien E, Barnaud G, Ricard J-D, Joly-Guillou M-L. Evaluation of a strategy of screening multiple anatomical sites for methicillin-resistant Staphylococcus aureus at admission to a teaching hospital. Infect Control Hosp Epidemiol 2006; 27:181-4.
15. Strausbaugh LJ, Jacobson C, Sewell DL, Potter S, Ward TT. Antimicrobial therapy for methicillin-resistant Staphylococcus aureus colonization in residents and staff of a Veterans Affairs nursing home care unit. Infect Control Hosp Epidemiol 1992; 13:151-9.
16. Walsh TJ, Standiford HC, Reboli AC, et al. Randomized double-blinded trial of rifampin with either novobiocin or trimethoprirn-sulfamethoxazole against methicillin-resistant Staphylococcus aureus colonization: prevention of antimicrobial resistance and effect of host factors on outcome. Antimicrob Agents Chemother 1993; 37:1334-42.
17. Muder RR, Boldin M, Brennen C, et al. A controlled trial of rifampin, minocycline, and rifampin plus minocycline for eradication of methicillin-resistant Staphylococcus aureus in long-term care patients. J Antimicrob Chemother 1994; 34:188-90.
18. Boyce JM. Preventing staphylococcal infections by eradicating nasal carriage of Staphylococcus aureus: proceeding with caution. Infect Control Hosp Epidemiol 1996; 17:775-9.
19. Bradley SF, Ramsey MA, Morton TM, Kauffman CA. Mupirocin resistance: clinical and molecular epidemiology. Infect Control Hosp Epidemiol 1995; 16:354-548.
20. Mody L, Kauffman CA, McNeil SA, Galecki AT, Bradley SF. Mupirocin decolonization of Staphylococcus aureus carriers in two long-term care facilities: a randomized, double-blinded, placebo-controlled trial. Clin Infect Dis 2003; 37:1467-74.
21. Watanakunakorn C, Brandt J, Durkin P, Santore S, Bota B, Stahl CJ. The efficacy of mupirocin ointment and chlorhexidine body scrubs in the eradication of nasal carriage of Staphylococcus aureus among patients undergoing long-term hemodialysis. Am J Infect Control 1992; 20:138-41.
22. Sandri AM, Dalarosa MG, de Alcantara LR, da Silva Elias L, Zavascki AP. Reduction in incidence of nosocomial methicillin-resistant Staphylococcus aureus (MRSA) infection in an intensive care unit: role of treatment with mupirocin ointment and chlorhexidine baths for nasal carriers of MRSA. Infect Control Hosp Epidemiol 2006; 27:185-7.
23. Kauffman CA, Terpenning MS, He X, et al. Attempts to eradicate methicillin-resistant Staphylococcus aureus from a long-term care facility with the use of mupirocin ointment. Am J Med 1993; 94:371-8.
24. Loeb M, Main C, Walker-Dilks C, Eady A. Antimicrobial drugs for treating methicillin-resistant Staphylococcus aureus colonization. CD003340. DOI: 10.1002/14651858.CD003340. Cochran Database Syst Rev 2003; 4.
25. Bommer J, Vergetis W, Andrassy K, Hingst V, Borneff M, Huber W. Elimination of Staphylococcus aureus in hemodialysis patients. ASAIO J 1995; 41:127-31.
26. Perez-Fontan M, Garcia-Falcon T, Rosales M, et al. Treatment of Staphylococcus aureus nasal carriers in continuous ambulatory peritoneal dialysis with mupirocin: long-term results. Am J Kidney Dis 1993; 22:708-12.
27. Martin JN, Perdreau-Remington F, Kartalija M, et al. A randomized clinical trial of mupirocin in the eradication of Staphylococcus aureus nasal carriage in human immunodeficiency virus disease. J Infect Dis 1999; 180: 895-9.
28. Tacconelli E, Carmeli Y, Aizer A, Ferrerira G, Foreman MG, D'Agata EMC. Mupirocin prophylaxis to prevent Staphylococcus aureus infection in patients undergoing dialysis: a meta-analysis. Clin Infect Dis 2003; 37:1629-38.
29. Diep BA, Gill SR, Chang RF, et al. Complete genome sequence of USA300, an epidemic clone of community-acquired methicillin-resistant Staphylococcus aureus. Lancet 2006; 367:731-9.
30. Weber DJ, Rutala WA. Use of germicides in the home and the healthcare setting: is there a relationship between germicide use and antibiotic resistance? Infect Control Hosp Epidemiol 2006; 27:1107-19.